Change in Novo Nordisk executive management
Effective today, Doug Langa, senior vice president for Market Access, Novo Nordisk Inc., has been appointed senior vice president, head of North America Operations and president of Novo Nordisk Inc.
Mr. Langa is senior Vice president, Market Access and a member of Novo Nordisk's US leadership team. He joined the company in 2011 as senior director, Managed Markets.
He came from GlaxoSmithKline where he was senior director of Payer Marketing.
Prior to GSK, Mr. Langa spent the majority of his career at Johnson & Johnson, where he held various roles of increasing responsibility within Managed Markets, Sales Leadership and Marketing.
He has over 25 years of experience in the pharmaceutical and medical device industry.
He graduated from Widener University and earned his MBA from Fordham University.
Mr. Riis will remain with Novo Nordisk in a transition period to help ensure a smooth handover. ■
What to read next
LATEST MOVES FROM Denmark
- Forward Pharma appoints Claus Bo Svendsen as CEO
- Hans Henrik Lund appointed CEO of Nilfisk
- Danske Bank appoints new CRO
- Maersk chairman Michael Pram Rasmussen to step down
- Maersk announces changes in executive management
More inside POST
RWE yearly net loss $6.02 billion Earnings
When to turn down a promotion Leadership